John Pawloski, MD, PhD
Stem Cell & Cellular Therapies Physician
Southeastern Regional Medical Center
"My wish is for all our patients to live longer and better lives. "
- John Pawloski, MD, PhD
- Doctor of Medicine and Doctor of Philosophy in Pharmacology - St. Louis University School of Medicine, St. Louis, MO
Internship / Residency
- Intern in Medicine and Junior Assistant Resident in Medicine - Duke University Medical Center, Durham, NC
- Internal Medicine & Hematology – American Board of Internal Medicine, American Board of Medical Specialties
- Clinical Investigator Fellow, Research Fellow, Fellow in Hematology/Oncology - Duke University Medical Center, Durham, NC
Practicing Since: 1994
Dr. John Pawloski, Stem Cell & Cellular Therapies Physician at Cancer Treatment Centers of America® (CTCA) in Atlanta, is dedicated to bringing patients the most advanced cancer care possible. “Step by step, strides are being made in the field of cancer treatment,” says Dr. Pawloski. “Many patients today can now live longer and experience fewer side effects than patients did years ago.”
Knowing early on that he would focus on medicine, Dr. Pawloski earned his Bachelor of Science in Biochemistry at the University of Michigan–Flint. He completed a combined Doctor of Medicine and Doctor of Philosophy degree at St. Louis University School of Medicine, preparing himself for a career as a physician-scientist, both treating patients and performing laboratory research.
His postgraduate training took place at Duke University Medical Center. He was a Medical Intern and then a Junior Assistant Resident. He spent two years as a Clinical Investigator Fellow and then a Research Fellow. Finally he completed a fellowship in Hematology/Oncology.
Following his training, Dr. Pawloski became Assistant Professor of Medicine at Duke University School of Medicine, and has gone on to hold he several clinical and academic positions. He served as Chief of the Section of Hematology at Allegheny General Hospital, where he also directed Hemostasis, Thrombosis & Anticoagulation services. He later became Associate Professor of Medicine at Drexel University College of Medicine, and then Chief of Hematology and Medical Director of Hematology, Blood Disorders & Regenerative Medicine at the John B. Amos Cancer Center.
Dr. Pawloski joined CTCA® in September 2015. Focused on treating hematologic malignancies including myeloma, leukemia and lymphoma, Dr. Pawloski is pioneering cellular therapies at CTCA, beginning with the establishment of the Hematology/Stem Cell Transplant Unit. Initially aimed for patients with acute leukemia, this unit will provide state-of-the-art stem cell transplants and other cellular therapies for many types of cancer. Newly emerging treatments, such as adoptive cellular immunotherapy, in which immune system cells are removed from the patient, modified to kill cancer cells, and then reinfused into the patient, will also be included in this unit.
Licensed to practice medicine by the States of Georgia, North Carolina, Alabama and Pennsylvania, Dr. Pawloski is Board Certified in Internal Medicine and Hematology by the American Board of Internal Medicine. He is a member of the American Society of Clinical Oncology, the American Society of Hematology, the American Heart Association and the American Physiological Society. He has received numerous awards and honors throughout his career and was named the Georgia Cancer Coalition Distinguished Clinician & Cancer Scholar in 2011. He has been an invited speaker and radio guest to discuss cancer and blood disorders.
Dr. Pawloski is also an active researcher, seeking to advance cancer treatment through clinical trials. He has served as a principal investigator on numerous studies, with current research focused on lymphoma and multiple myeloma. His studies and commentaries are published in many medical journals including Nature, the Proceedings of the National Academy of Sciences, the New England Journal of Medicine, and Transfusion.
Outside of CTCA, Dr. Pawloski enjoys spending time with his wife of 29 years and their three grown children. When he is not cooking or doing home renovations, he can be found caring for their horses, dogs, cats and snakes, landscaping, and traveling to speak about advances in the treatment of hematologic malignances.